Biosimulation market is predicted to expand at a CAGR of 16.54% over the period 2018-2024

Knowledge Sourcing Intelligence announces the publication of a new report on "Biosimulation Market- Forecasts from 2019 to 2024" to their offering.Biosimulation is a machine-aided simulation of biological processes and systems. This is used to study the response of the human organ to any chemical change brought to it.

This report provides forecast and analysis of the Biosimulation Market which is estimated to reach US$4,673.474 million by 2024. The rising number of diseases and the increasing geriatric population across the globe are driving technological advancements in the field of medical sciences. Biosimulation is a technique used to predict how the human body will react to certain medicines or chemical changes. Investments in Research and Development in the fields of Medical science is expected to fuel the growth of this market. Climatic and lifestyle changes have brought the dawn of a plethora of new diseases for individuals, for which new drugs have to be developed continuously. The rising dependence on packaged and ready-to-mix foods has adversely affected the health of human beings. Polluted air is major cause of concern due to rising cases of respiratory diseases. The biosimulation market enables to deliver personalized drugs for different patients groups. Besides, personal healthcare expenditure is also rising with escalating health awareness among masses. This is also driving the growth in this market. Additionally, the regulatory bodies are leveraging biosimulation equipment to test various drugs for approval. The main applications of biosimulation are developing and discovering the drugs at a lower cost which bolsters the growth of this market. However, the lack of standardization in the method of conducting biosimulation is still a concern and is expected to affect the working of this market. Lack of skilled personnel and inappropriate infrastructure facilities may also act as restraining factors in this market. Geographically, the North American region is expected to hold a substantial share in this market owing to the technological advancements happening in this region in the medical drugs and device industry. Asia-Pacific region is anticipated to witness slow growth as it is in the birth stage in this market.

Some of the major players covered as part of the report Certara USA, Inc., Schrodinger, LLC, Simulations Plus, Chemical Computing Group Inc., and Physiomics PLC among others.

This report segmented the Biosimulation Marketon the basis following terms:
o By Type
o Software
o Services

o By Application
o Drug Development
o Drug Discovery
o Others

o By End-User Industry
o Pharmaceutical Companies
o Academic Institutions
o Research Organizations
o Others

o By Geography
o North America
o United States
o Canada
o Mexico

o South America
o Brazil
o Argentina
o Others

o Europe
o Germany
o France
o UK
o Spain
o Others

o The Middle East and Africa
o Israel
o Saudi Arabia
o Others

o Asia Pacific
o China
o Japan
o South Korea
o India
o Others

Purchase complete report or request sample https://www.knowledge-sourcing.com/report/biosimulation-market

Suite 406, H-140,
Sector 63, Noida,
U.P., India - 201301

Knowledge Sourcing Intelligence (KSI) is a market research and consulting firm publishing market research studies spanning across ten industry verticals. KSI has a team of experienced and young professionals with a singular focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports per year centering on the niche and latest technologies. We engage with key decision-makers and stakeholders across the value chain to provide clients with a detailed analysis and bird's-eye view of the market with complete market dynamics, statistical forecasts, competitive analysis, key trends, market drivers and challenges and strategic recommendations for making informed decisions. Our success lies in the effort of our analysts who strive to meet client expectations by delivering quality work within the stipulated deadlines.

This release was published on openPR.